Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rangering i aksjer #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aksjekurs
$36.75
Sist synkronisert: 2026-08-27
Markedsverdi
$1.63B
Endring (1 dag)
-0.78%
Endring (1 år)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Aksjeprishistorikk for Avalyn Pharma Inc. Common Stock (AVLN)
Høyeste sluttskurs: $36.94 den 2026-08-01

Laveste sluttskurs: $29.49 den 2026-04-01
Aksjeprishistorikk for Avalyn Pharma Inc. Common Stock fra 2026 til 2026
Årlig aksjeprisytelse
År Ytelse
Ikke nok data for de angitte datoene.
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$762.91 7.41%
CH